GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Thumb Industries Inc (XCNQ:GTII) » Definitions » Debt-to-EBITDA

Green Thumb Industries (XCNQ:GTII) Debt-to-EBITDA : 1.89 (As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is Green Thumb Industries Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Green Thumb Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$21 Mil. Green Thumb Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$745 Mil. Green Thumb Industries's annualized EBITDA for the quarter that ended in Dec. 2023 was C$406 Mil. Green Thumb Industries's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.89.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Green Thumb Industries's Debt-to-EBITDA or its related term are showing as below:

XCNQ:GTII' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.24   Med: 1.76   Max: 70.08
Current: 1.75

During the past 13 years, the highest Debt-to-EBITDA Ratio of Green Thumb Industries was 70.08. The lowest was 1.24. And the median was 1.76.

XCNQ:GTII's Debt-to-EBITDA is ranked worse than
51.6% of 657 companies
in the Drug Manufacturers industry
Industry Median: 1.69 vs XCNQ:GTII: 1.75

Green Thumb Industries Debt-to-EBITDA Historical Data

The historical data trend for Green Thumb Industries's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Thumb Industries Debt-to-EBITDA Chart

Green Thumb Industries Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.08 1.24 1.31 1.98 1.76

Green Thumb Industries Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.15 1.64 1.75 1.61 1.89

Competitive Comparison of Green Thumb Industries's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Thumb Industries's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Green Thumb Industries's Debt-to-EBITDA falls into.



Green Thumb Industries Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Green Thumb Industries's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(20.517 + 744.576) / 434.87
=1.76

Green Thumb Industries's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(20.517 + 744.576) / 405.868
=1.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Green Thumb Industries  (XCNQ:GTII) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Green Thumb Industries Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Green Thumb Industries's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Thumb Industries (XCNQ:GTII) Business Description

Traded in Other Exchanges
Address
325 West Huron Street, Suite 700, Chicago, IL, USA, 60654
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 15 states and operates roughly 87 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to U.S. federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles and RYTHM.

Green Thumb Industries (XCNQ:GTII) Headlines

From GuruFocus

Global Tech Industries Group, Inc. Bids $100 Million in Stock for Acquisition of Creatd.

By Stock market mentor Stock market mentor 01-10-2023

Global Tech Industries Group, Inc. Updates its Website

By Value_Insider Value_Insider 10-15-2022